MTRNR2L7: A Potential Drug Target and Biomarker (G100288485)
MTRNR2L7: A Potential Drug Target and Biomarker
MTRNR2L7, a gene located on chromosome 6, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. Its unique genetic makeup and expressed levels in various tissues make it an attractive target for researchers to investigate.
MTRNR2L7 is a non-coding RNA molecule that is expressed in various tissues and organs, including brain, heart, liver, and pancreas. It is a part of the microRNA (miRNA) family, which are small non-coding RNAs that play a crucial role in post-transcriptional gene regulation. MTRNR2L7 is known for its unique ability to interact with miRNA-containing complexes, which may influence the stability and translation of target miRNAs.
Studies have shown that MTRNR2L7 is involved in various cellular processes, including cell growth, apoptosis, and inflammation. It has been shown to regulate the expression of genes involved in cell adhesion, migration, and invasion, as well as in the production of extracellular matrix (ECM) components.
MTRNR2L7 has also been linked to several diseases and conditions, including cancer, neurodegenerative disorders, and autoimmune diseases. For example, studies have shown that MTRNR2L7 is overexpressed in various types of cancer, including breast, ovarian, and colorectal cancer. This increased expression may contribute to the development and progression of these diseases.
In addition to its potential clinical applications, MTRNR2L7 is also a potential biomarker for some diseases. The expression of MTRNR2L7 has been shown to be downregulated in various tissues and conditions, including cancer, neurodegenerative disorders, and autoimmune diseases. This suggests that MTRNR2L7 may serve as a diagnostic or therapeutic target in these conditions.
The potential drug target for MTRNR2L7 is currently being investigated in various clinical trials. Studies have shown that inhibiting the activity of MTRNR2L7 using small interfering RNA (siRNA) or CRISPR/Cas9 genome editing technology can lead to therapeutic effects in various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.
In conclusion, MTRNR2L7 is a promising drug target and biomarker for various diseases. Its unique genetic makeup and expressed levels in various tissues make it an attractive target for researchers to investigate. Further studies are needed to fully understand the role of MTRNR2L7 in various biological processes and to develop effective therapies based on this target.
Protein Name: MT-RNR2 Like 7 (pseudogene)
Functions: Plays a role as a neuroprotective and antiapoptotic factor
The "MTRNR2L7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTRNR2L7 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MTRNR2L8 | MTRNR2L9 | MTRR | MTSS1 | MTSS2 | MTTP | MTURN | MTUS1 | MTUS1-DT | MTUS2 | MTUS2-AS1 | MTVR2 | MTX1 | MTX2 | MTX3 | mu-Calpain (calpain 1) | MUC1 | MUC12 | MUC13 | MUC15 | MUC16 | MUC17 | MUC19 | MUC2 | MUC20 | MUC20P1 | MUC21 | MUC22 | MUC3A | MUC3B | MUC4 | MUC5AC | MUC5B | MUC6 | MUC7 | MUC8 | Mucin | MUCL1 | MUCL3 | MUL1 | Multisubunit histone acetyltransferase complex | MUPP | MUS81 | Muscarinic Acetylcholine Receptor (mAChR) | MUSK | MUSTN1 | MUTYH | MVB12A | MVB12B | MVD | MVK | MVP | MX1 | MX2 | MXD1 | MXD3 | MXD4 | MXI1 | MXRA5 | MXRA5Y | MXRA7 | MXRA8 | MYADM | MYADML | MYADML2 | MYB | MYBBP1A | MYBL1 | MYBL2 | MYBPC1 | MYBPC2 | MYBPC3 | MYBPH | MYBPHL | MYC | MYCBP | MYCBP2 | MYCBP2-AS1 | MYCBPAP | MYCL | MYCL-AS1 | MYCLP1 | MYCN | MYCNOS | MYCNUT | MYCT1 | MYD88 | MYDGF | MYEF2 | Myelin Protein | MYEOV | MYF5 | MYF6 | MYG1 | MYH1 | MYH10 | MYH11 | MYH13 | MYH14 | MYH15
